26 results
Spotlights of key learnings for the future pandemic preparedness and response,Spotlights of key learnings for the future pandemic preparedness and response
The following report displays data and figures on the introduction status of pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV) both globally and in 73 Gavi...
The following report displays data and figures on the introduction status of pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV) both globally and in 73 Gavi...
Руководство по оперативному развертыванию для стран.
Guide de déploiement opérationnel à l’intention des pays.
Guía de implantación operativa para los países.
Gavi, the Vaccine Alliance is a global public-private partnership with the goal of supporting the national governments of low-income countries in their efforts to increase equal access to vaccines....
The following report displays data and figures on the introduction status of pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV) both globally and in 73 Gavi...
Nearly all of the 500,000 new cases of cervical cancer and 270,000 deaths occur in middle or lower income countries. Yet the two most prevalent HPV vaccines are unaffordable to most. Even prices to...
Since 2011, a five-year strategy has guided Gavi’s mission to save children’s lives and protect people’s health by increasing access to immunisation. In this edition of its Annual Progress...
Technet was relaunched at the 2001 conference as Technet21. The New Delhi 2001 meeting, organized back-to-back with SIGN, welcomed a total of 107 participants including 23 participants representing...
Few countries in Africa currently include rubella-containing vaccination (RCV) in their immunization schedule. The Global Alliance for Vaccines Initiative (GAVI) recently opened a funding window that...
Lauded for getting specific health issues onto national and international agendas and for their potential to improve value for money and outcomes, public-private global health initiatives (GHIs) have...
GAVI’s focus on reducing inequities in access to vaccines, immunization, and GAVI funds, − both between and within countries - has changed over time. This paper charts that evolution.
This evaluation assesses the extent to which the Advanced Market Commitment (AMC) pilot has achieved its stated objectives and the overarching goal to “reduce morbidity and mortality from...
This report presents the findings of the Outcomes and Impact evaluation for the Pilot Advance Market Commitment (AMC) for Pneumococcal Vaccines. This evaluation was conducted in 2015 by The Boston...
Middle-income countries (MICs) as a group are not only characterized by a wide range of gross national income (GNI) per capita (US $1026 to $12,475), but also by diversity in size, geography,...
Over the past several years, the development of new vaccines, along with global efforts to make them more available and affordable, has resulted in the introduction of lifesaving vaccines in...
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX...
The Gavi Full Country Evaluations was a prospective study from 2013 to 2016 in four countries: Bangladesh, Mozambique, Uganda, and Zambia. The study aimed to understand and quantify the barriers and...
Keynote address delivered at the 2021 GVIRF.